Table 5. Patients with ambiguous morphological findings, which are analyzed with the MDS/MPN-Panel to precise the diagnosis.

Suspected myeloid neoplasm	No. patients with detectable variant
MDS (n = 55)	24 (43.6%)
MPN (n = 9)	4 (44.4%)
CMML (n = 18)	14 (77.8%)
Other* (n = 5)	2 (40.0%)

Other* include aCML, CML and MDS/MPN-U